HDAC-IN-44 structure
|
Common Name | HDAC-IN-44 | ||
---|---|---|---|---|
CAS Number | 2414921-46-1 | Molecular Weight | 539.42 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H27BrN4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HDAC-IN-44HDAC-IN-44 is a HDAC inhibitor with the IC50 value of 61.2 nM. HDAC-IN-44 shows high anticancer activity towards multiple cancer cell lines[1]. |
Name | HDAC-IN-44 |
---|
Description | HDAC-IN-44 is a HDAC inhibitor with the IC50 value of 61.2 nM. HDAC-IN-44 shows high anticancer activity towards multiple cancer cell lines[1]. |
---|---|
Related Catalog | |
In Vitro | HDAC-IN-44 (20 µg/mL; 24 h) treatment shows inhibitory effects on acute lymphoblastic leukemia (Molt 4 cells), T-cell lymphoblastic lymphoma (Sup-T1 cells), chronic myelogenous leukemia (K562 cells), gastric adenocarcinoma (AGS), prostate cancer (PC3 and LNCaP cells) and breast cancer (T47D cells) [1]. Cell Viability Assay Cell Line: Molt 4, Sup-T1, K562, AGS, PC-3, LNCaP, T47D cells[1] Concentration: 20 µg/mL Incubation Time: 24 hours Result: Exhibited IC50 values of 11, 9.1, 16.3, 7.1, 13.4, 32.7 and 9.2 μM in Molt 4, Sup-T1, K562, AGS, PC-3, LNCaP, T47D cells, respectively[1]. |
References |
Molecular Formula | C26H27BrN4O4 |
---|---|
Molecular Weight | 539.42 |